EMIS never fully recovered from its disastrous phase-2 oral-insulin trial in India and the disingenuous way in which it presented the results (#msg-14395914, #msg-14397293).
“The notion that there’s a Chinese Wall between sell-side analysts and investment bankers may be the second-biggest piece of BS ever promulgated in any area of human knowledge!”